<?xml version="1.0" encoding="utf-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
>

<channel rdf:about="http://www.biochemj.org">
<title>BJ ChemBio Immediate Publications</title>
<link>http://www.biochemj.org</link>
<description>Biochemical Journal RSS feed -- BJ ChemBio Immediate Publications</description>
<prism:issn>0264-6021</prism:issn>
<prism:eIssn>1470-8728</prism:eIssn>
<prism:publicationName>Biochemical Journal</prism:publicationName>
<items>
 <rdf:Seq>
	<rdf:li rdf:resource="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112113" />
	<rdf:li rdf:resource="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120433" />
	<rdf:li rdf:resource="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120499" />
	<rdf:li rdf:resource="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20111840" />
	<rdf:li rdf:resource="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112103" />
	<rdf:li rdf:resource="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120408" />
	<rdf:li rdf:resource="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112032" />
	<rdf:li rdf:resource="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120036" />
	<rdf:li rdf:resource="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112219" />
	</rdf:Seq>
</items>
<image rdf:resource="http://www.biochemj.org/images/BJ_Name.gif" />
</channel>

<image rdf:about="http://www.biochemj.org/images/BJ_Name.gif">
<title>Biochemical Journal</title>
<url>http://www.biochemj.org/images/BJ_Name.gif</url>
<link>http://www.biochemj.org</link>
</image>

<item rdf:about="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112113">
	<title><![CDATA[Structure and activity of the cold-active and anion-activated carboxyl esterase OLEI01171 from the oil-degrading marine bacterium Oleispira antarctica]]></title>
	<link>http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112113</link>
	<description><![CDATA[The uncharacterized &#x03B1;/&#x03B2;-hydrolase protein OLEI01171 from the psychrophilic marine bacterium <i>Oleispira antarctica</i> belongs to the PF00756 family of putative esterases, which also includes human esterase D. Here we show that purified recombinant OLEI01171 exhibites high esterase activity against the model esterase substrate &#x03B1;-naphthyl acetate at 5 &#x00B0;C &#x2013; 30 &#x00B0;C with maximal activity at 15 &#x00B0;C &#x2013; 20 &#x00B0;C. The esterase activity of OLEI01171 was stimulated 3-8 times by the addition of chloride or several other anions (0.1 M &#x2013; 1.0 M). Compared to mesophilic PF00756 esterases, OLEI01171 exhibited lower overall protein thermostability. Two crystal structures of OLEI01171 were solved at 1.75 and 2.1 &#x00C5; resolution and revealed a classical Ser hydrolase catalytic triad and the presence of a chloride or bromide ion bound in the active site close to the catalytic Ser148. Both anions were found to coordinate a potential catalytic water molecule located in the vicinity of the catalytic triad His257. Our data suggest that the bound anion perhaps contributes to the polarization of the catalytic water molecule and increases the rate of the hydrolysis of an acyl-enzyme intermediate. Alanine replacement mutagenesis of OLEI01171 identified ten amino acid residues important for esterase activity. The replacement of Asn225 by Lys had no significant effect on the OLEI01171 activity or thermostability, but resulted in a detectable increase of activity at 35 &#x00B0;C to 45 &#x00B0;C. Our work has provided insight into the molecular mechanisms of activity of a cold-active and anion-activated carboxyl esterase.]]></description>
	<dc:creator>S Lemak, A Tchigvintsev, P Petit, R Flick, A U. Singer, G Brown, E Evdokimova, O Egorova, C Gonzalez, T N. Chernikova, M M. Yakimov, M Kube, R Reinhardt, P N. Golyshin, A Savchenko, A F. Yakunin</dc:creator>
	<dc:date>2012-04-23T09:00:00Z</dc:date>
	<dc:identifier>doi:10.1042/BJ20112113</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-04-23</prism:publicationDate>
	<prism:section>BJ Structure</prism:section>
</item>

<item rdf:about="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120433">
	<title><![CDATA[A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell mediated lysis of prostate cancer cells]]></title>
	<link>http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120433</link>
	<description><![CDATA[A disintegrin and metalloproteinase 17 (ADAM17) is a membrane-bound protease that
cleaves various cell surface proteins including cytokines and cytokine receptors.
Recently it was shown that ADAM17 is highly expressed on the surface of many cancer
cells whereas normal cells express low levels of ADAM17, implying ADAM17 as a
potential immunotherapeutic target. We have generated a monoclonal antibody against
human ADAM17, which recognized the membrane proximal cysteine-rich extension of
the ADAM17 protein. Unlike normal cells, tumor cell lines such as a prostate cancer
cell line, pancreatic cancer cell lines, a breast cancer cell line and a non-small lung
cancer cell line expressed ADAM17 on the cell surface. Using the sequence of the
antibody we generated an ADAM17-specific single-chain antibody (scFv) and fused
this to a CD3-specific scFv to generate a bispecific T-cell engager antibody
(A300E-BiTE). Specificity was demonstrated on cells in which ADAM17 was knocked
down with a specific shRNA. A300E-BiTE recognized ADAM17 and CD3 on the cell
surface of tumor cells and T-cells, respectively. In the presence of primary human
peripheral blood mononuclear cells or human T-cells addition of A300E-BiTE led to
ADAM17 specific killing of prostate tumor cells indicating a novel strategy for the
treatment of cancer.]]></description>
	<dc:creator>K Yamamoto, A Trad, A Baumgart, L H&#x00FC;ske, I Lorenzen, A Chalaris, J Gr&#x00F6;tzinger, T Dechow, J Scheller, S Rose-John</dc:creator>
	<dc:date>2012-04-17T15:27:08Z</dc:date>
	<dc:identifier>doi:10.1042/BJ20120433</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-04-17</prism:publicationDate>
	<prism:section>BJ Cell</prism:section>
</item>

<item rdf:about="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120499">
	<title><![CDATA[Definition of the binding mode of a new class of phosphoinositide inositol 3-kinase alpha-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysis.]]></title>
	<link>http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120499</link>
	<description><![CDATA[The binding mechanism of a new class of lipid competitive, ATP non-competitive, p110a isoform selective phosphoinositide-3-kinase (PI3K) inhibitors has been elucidated. Using the novel technique of isoform reciprocal mutagenesis of non-conserved amino acids in the p110alpha and p110beta isoforms we have identified three unique binding mechanisms for the p110alpha-selective inhibitors, PIK-75, A-66S and J-32. Each inhibitor&#x2019;s p110alpha-isoform selective binding was found to be due to interactions with different amino acids within p110. PIK-75 interaction bound the non-conserved region 2 amino acid, p110alpha S773, A-66S bound the region 1 non-conserved amino acid, p110alpha Q859, and J-32 binding had indirect interaction with K776 and I771. The isoform reciprocal mutagenesis technique is shown to be an important analytical tool for the rational design of isoform-selective inhibitors.]]></description>
	<dc:creator>Z Zheng, S Itri Amran, J Zhu, O Schmidt-Kittler, K W Kinzler, B Vogelstein, P R Shepherd, P E Thompson, I G Jennings</dc:creator>
	<dc:date>2012-04-13T13:47:54Z</dc:date>
	<dc:identifier>doi:10.1042/BJ20120499</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-04-13</prism:publicationDate>
	<prism:section>BJ ChemBio</prism:section>
</item>

<item rdf:about="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20111840">
	<title><![CDATA[Generation of free ubiquitin chains is upregulated in stress, and facilitated by the HECT domain ubiquitin ligases UFD4 and HUL5]]></title>
	<link>http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20111840</link>
	<description><![CDATA[Polyubiquitin chains serve a variety of physiological roles. Typically, the chains are bound covalently to a protein substrate, and in many cases target it for degradation by the 26S proteasome. However, several studies have demonstrated the existence of free polyubiquitin chains which are not linked to a specific substrate. Several physiological functions have been attributed to these chains, among them playing a role in signal transduction and serving as storage of ubiquitin for utilization under stress. In this study, we have established a system for detection of free ubiquitin chains and monitoring their level under changing conditions. Using this system, we show that UFD4, a HECT domain ubiquitin ligase, is involved in free chains generation. We also show that generation of these chains is stimulated in response to a variety of stresses, particularly that caused by DNA damage. However, it appears that the stress-induced synthesis of free chains is catalyzed by a different ligase, HUL5, which is also a HECT domain E3.]]></description>
	<dc:creator>O Braten, N Shabek, Y Kravtsova-Ivantsiv, A Ciechanover</dc:creator>
	<dc:date>2012-04-13T11:23:37Z</dc:date>
	<dc:identifier>doi:10.1042/BJ20111840</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-04-13</prism:publicationDate>
	<prism:section>BJ ChemBio</prism:section>
</item>

<item rdf:about="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112103">
	<title><![CDATA[Bax, Bcl-xL Exert their regulation on different sites of the ceramide channel]]></title>
	<link>http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112103</link>
	<description><![CDATA[This study demonstrates the important structural features of ceramide required for proper regulation, binding and identification by both pro-apoptotic and anti-apoptotic Bcl-2 family proteins. The C4:C5 <i>trans </i>double bond has little influence on the ability of Bax and Bcl-xL to identify and bind to these channels. The stereochemistry of the head group and access to the amide N-H group of ceramide is indispensible for Bax binding indicating that Bax may be interacting with the polar portion of the ceramide channel facing the bulk phase. On the contrary, Bcl-xL binding to ceramide channels is tolerant of stereochemical changes in the head group. This study also revealed that Bcl-xL has an optimal interaction with long-chain ceramides that are elevated early in apoptosis while short-chain ceramides are not well regulated. Inhibitors specific for the hydrophobic groove of Bcl-xL including 2-methoxyantimycin A<sub>3</sub>, ABT-737, and ABT-263 provide insights into the region of Bcl-xL involved in binding to ceramide channels. Molecular docking simulations of the lowest energy binding poses of ceramides and Bcl-xL inhibitors to Bcl-xL were consistent with the results of our functional studies and propose potential binding modes.]]></description>
	<dc:creator>M N Perera, S H Lin, Y K Peterson, A Bielawska, Z M. Szulc, R Bittman, M Colombini</dc:creator>
	<dc:date>2012-04-11T13:31:33Z</dc:date>
	<dc:identifier>doi:10.1042/BJ20112103</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-04-11</prism:publicationDate>
	<prism:section>BJ ChemBio</prism:section>
</item>

<item rdf:about="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120408">
	<title><![CDATA[Distinctive Binding of Three Antagonistic Peptides to the Ephrin-Binding Pocket of the EphA4 Receptor]]></title>
	<link>http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120408</link>
	<description><![CDATA[The EphA4 receptor tyrosine kinase interacts with ephrin ligands to regulate many processes,
ranging from axon guidance and nerve regeneration to cancer malignancy. Thus, antagonists that
inhibit ephrin binding to EphA4 could be useful for a variety of research and therapeutic
applications. Here we characterize the binding features of three antagonistic peptides (KYL,
APY and VTM) that selectively target EphA4 among the Eph receptors. Isothermal titration
calorimetry analysis demonstrates that all three peptides bind to the ephrin-binding domain of
EphA4 with low micromolar affinity. Furthermore, the effects of a series of EphA4 mutations
suggest that the peptides interact in different ways with the ephrin-binding pocket of EphA4.
Chemical shifts observed by NMR spectroscopy upon binding of the KYL peptide involve many
EphA4 residues, consistent with extensive interactions and possibly receptor conformational
changes. Additionally, systematic replacement of each of the 12 amino acids of KYL and VTM
identify the residues critical for EphA4 binding. The peptides exhibit a long half-life in cell
culture medium, which with their substantial binding affinity and selectivity for EphA4 makes
them excellent research tools to modulate EphA4 function.]]></description>
	<dc:creator>I Lamberto, H Qin, R Noberini, L Premkumar, C Bourgin, S Riedl, J Song, E B. Pasquale</dc:creator>
	<dc:date>2012-04-10T14:53:24Z</dc:date>
	<dc:identifier>doi:10.1042/BJ20120408</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-04-10</prism:publicationDate>
	<prism:section>BJ ChemBio</prism:section>
</item>

<item rdf:about="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112032">
	<title><![CDATA[Structure and activity of the Pseudomonas aeruginosa hotdog-fold thioesterases PA5202 and PA2801]]></title>
	<link>http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112032</link>
	<description><![CDATA[The hotdog fold is one of the basic protein folds widely present in bacteria, archaea, and eukaryotes. Many of these proteins exhibit thioesterase activity against fatty acyl-CoAs and play important roles in lipid metabolism, cellular signaling, and degradation of xenobiotics. The genome of the opportunistic pathogen <i>Pseudomonas aeruginosa</i> contains over 20 genes encoding predicted hotdog-fold proteins, none of which have been experimentally characterized. We have found that two <i>P. aeruginosa</i> hotdog proteins display high thioesterase activity against 3-hydroxy-3-methylglutaryl-CoA and glutaryl-CoA (PA5202), and octanoyl-CoA (PA2801). Crystal structures of these proteins were solved (1.70 and 1.75 &#x00C5;) and revealed a hotdog fold with a potential catalytic carboxylate residue located on the long alpha helix (Asp57 in PA5202 and Glu35 in PA2801). Alanine replacement mutagenesis of PA5202 identified four residues (Asn42, Arg43, Asp57, and Thr76), which are critical for activity and are located in the active site. A <i>P. aeruginosa</i> PA5202 deletion strain showed an increased secretion of the antimicrobial pigment pyocyanine and an increased expression of genes involved in pyocyanin biosynthesis suggesting a functional link between the PA5202 activity and pyocyanin production. Thus, the <i>P. aeruginosa</i> hotdog thioesterases PA5202 and PA2801 have similar structures, but exhibit different substrate preferences and functions.]]></description>
	<dc:creator>C Gonzalez, A Tchigvintsev, G Brown, R Flick, E Evdokimova, X Xu, J Osipiuk, M Cuff, S Lynch, A Joachimiak, A Savchenko, A F. Yakunin</dc:creator>
	<dc:date>2012-03-23T10:59:46Z</dc:date>
	<dc:identifier>doi:10.1042/BJ20112032</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-03-23</prism:publicationDate>
	<prism:section>BJ Structure</prism:section>
</item>

<item rdf:about="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120036">
	<title><![CDATA[A glycosynthase derived from an inverting GH19 chitinase from the moss Bryum coronatum]]></title>
	<link>http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20120036</link>
	<description><![CDATA[BcChi-A, a GH19 chitinase from the moss <i>Bryum coronatum,</i> is an endo-acting enzyme that hydrolyzes glycosidic bonds of chitin, a &#x03B2;-1,4-linked polysacharide of <i>N</i>-acetylglucosamine, (GlcNAc)<sub>n</sub>, through an inverting mechanism. When the wild-type enzyme was incubated with alpha-(GlcNAc)<sub>2</sub> fluoride [alpha-(GlcNAc)<sub>2</sub>-F] in the absence or presence of (GlcNAc)<sub>2</sub>, (GlcNAc)<sub>2</sub> and hydrogen fluoride were found to be produced through the Hehre resynthesis-hydrolysis mechanism. To convert BcChi-A into a glycosynthase, we employed the strategy reported by Honda et al. (<i>J. Biol. Chem.</i> 281, 1426-1431 (2006); <i>Glycobiology</i>, 18, 325-330 (2008)); that is, Ser102 holding a nucleophilic water molecule and Glu70 acting as a catalytic base were mutated, producing S102A, S102C, S102D, S102G, S102H, S102T, E70G, and E70Q. In all mutated enzymes except S102T, hydrolytic activity toward (GlcNAc)<sub>6</sub> was not detected under the conditions we employed. Among the inactive BcChi-A mutants, S102A, S102C, S102G, and E70G were found to successfully synthesize (GlcNAc)<sub>4</sub> as a major product from alpha-(GlcNAc)<sub>2</sub>-F in the presence of (GlcNAc)<sub>2</sub>. The S102A mutant showed the greatest glycosynthase activity due to its enhanced F<sup>-</sup> releasing activity and its suppressed hydrolytic activity. This is the first report on a glycosynthase that employs amino sugar fluoride as a donor substrate.]]></description>
	<dc:creator>T Ohnuma, T Fukuda, S Dozen, Y Honda, M Kitaoka, T Fukamizo</dc:creator>
	<dc:date>2012-03-21T14:14:03Z</dc:date>
	<dc:identifier>doi:10.1042/BJ20120036</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-03-21</prism:publicationDate>
	<prism:section>BJ Structure</prism:section>
</item>

<item rdf:about="http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112219">
	<title><![CDATA[The disordered N-terminal region of dengue virus capsid protein contains a lipid droplet-binding motif]]></title>
	<link>http://www.biochemj.org/bj/imps/refer.htm?MSID=BJ20112219</link>
	<description><![CDATA[Dengue is the major arthropod-borne human viral disease, for which no vaccine or specific treatment are available. We used nuclear magnetic resonance, zeta potential measurements and atomic force microscopy to study the structural features of the interaction between dengue virus capsid (C) protein and lipid droplets (LDs), organelles crucial for infectious particles formation. C protein binding sites to LD were mapped, revealing a new function for a conserved segment in the N-terminal disordered region, and indicating that conformational selection is involved in recognition. The results suggest that C protein positively-charged N-terminal region prompts the interaction with negatively-charged LDs, after which a conformational rearrangement enables the access of the central hydrophobic patch to LD surface. Altogether, the results allowed the design of a peptide with inhibitory activity of C protein-LD binding, paving the way for new drug development approaches against dengue.]]></description>
	<dc:creator>I C Martins, F Gomes-Neto, A F Faustino, F A Carvalho, F A Carneiro, P T Bozza, R Mohana-Borges, M A Castanho, F C Almeida, N C. Santos, A T Da Poian</dc:creator>
	<dc:date>2012-03-19T14:50:05Z</dc:date>
	<dc:identifier>doi:10.1042/BJ20112219</dc:identifier>
	<dc:publisher>Portland Press Limited</dc:publisher>
	<prism:publicationDate>2012-03-19</prism:publicationDate>
	<prism:section>BJ ChemBio</prism:section>
</item>





</rdf:RDF>

